CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors
Publication
, Conference
Logan, K; Huang, J; Morse, M; Shi, C
Published in: MODERN PATHOLOGY
2022
Duke Scholars
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
2022
Volume
35
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Logan, K., Huang, J., Morse, M., & Shi, C. (2022). CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In MODERN PATHOLOGY (Vol. 35, pp. 488–489).
Logan, Kristen, Jiaoti Huang, Michael Morse, and Chanjuan Shi. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” In MODERN PATHOLOGY, 35:488–89, 2022.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In: MODERN PATHOLOGY. 2022. p. 488–9.
Logan, Kristen, et al. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” MODERN PATHOLOGY, vol. 35, 2022, pp. 488–89.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. MODERN PATHOLOGY. 2022. p. 488–489.
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
2022
Volume
35
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences